ICaPath
Manufacturing · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1812 Ashland Ave Ste 100, Baltimore, Mar...Website
www.icapath.comRevenue
<$5 MillionIndustry
ZI Rank: 1
About ICaPath
ICaPath Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ICaPath your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if ICaPath is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
ICaPath, which may be a good buyer, showed buying intent in Masked Content Topic
Check if ICaPath has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on ICaPath recently announced quarterly report
Product Launch: Get notified when ICaPath launches new products
Click to see if ICaPath had a recent Job posting/layoffs
Funding: Get notified immidiatlly once ICaPath has new funding data
Congratulate Masked Content for being promoted to Masked Content at ICaPath
Recommended Actions
Find VP level buyers at ICaPath
Find 3 more new buyers
Company Profile Activity
Activity Insights
ICaPath is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ICaPath is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ICaPath.
ICaPath Tech Stack
A closer look at the technologies used by ICaPath
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ICaPath
ICaPath is a biotechnology company focused on developing innovative cancer therapies using its proprietary PLGA nanoparticle platform. The company specializes in the manufacturing of rHu IL-12 and PLGA nanoparticles under GMP guidelines, aiming to enhance the efficacy and safety of immunotherapy treatments. Their target clients include healthcare p... Read More
